Clinerion and Datametrix Partner to Deliver Real World Evidence (RWE) Insights from Real World Data (RWD) from Clinerion’s Global Hospital Network
Summary
Together, Clinerion and Datametrix will power Real World Evidence (RWE) research and bring insights on the realities of clinical practice and outcomes. They will enable Real World Data (RWD) research to investigate differential treatment outcomes in support of optimizing care protocols. “We believe that data collected in an organized and simple manner, then analyzed using the right analytical tools will empower pharmaceutical and biotechnology companies to bring better drugs to market faster,” says Ahmed El Rhali, CEO of Datametrix. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. For more information, please contact: Ahmed El Rhali CEO Datametrix AG Faubourg de l’Hopital 3, Neuchâtel, Switzerland Tel.